Pain News and Research

Latest Pain News and Research

SANUWAVE Health introduces orthoPACE device in Europe

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reports the European launch of the orthoPACE device intended for use in orthopedic, trauma and sports medicine indications following CE mark approval last month.

14 Jul 2010

Circular external fixator enables over 90% of Charcot foot patients to walk normally again

The alarming increase of morbidly obese diabetics is causing more new cases of a debilitating foot deformity called Charcot foot.

14 Jul 2010

Telecare management intervention improves pain, depression in cancer patients

Cancer patients receiving care in geographically dispersed urban and rural oncology practices who participated in a program that included telephone-based care management and home-based automated symptom monitoring had greater improvement in pain and depression compared to patients who received usual care, according to a study in the July 14 issue of JAMA.

14 Jul 2010

Therapeutic workbook to facilitate healing process in Haitian children

"When children can tell their stories about a traumatic event in their own words or pictures and at their own speed, healing can begin," says Dr. Jodie Kliman, psychologist and professor at the Massachusetts School of Professional Psychology (MSPP) in Boston. That is why Kliman led MSPP's collaboration with the Children's Psychological Health Center (CPHC) in San Francisco and Ekol Akasya (Acacia School) in Haiti to create a workbook to facilitate that healing process in Haitian children and to identify those at greatest risk for long-term emotional problems.

14 Jul 2010

Zogenix secures $35M financing for commercial launch of SUMAVEL DosePro needle-free delivery system

Zogenix, Inc., a privately held pharmaceutical company, announced that it has secured a $35 million debt facility led by Oxford Finance Corporation which also included Silicon Valley Bank. The facility consists of a $25 million term loan and a $10 million revolving line of credit. Concurrently, all existing Zogenix investors, including Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas, McNerney & Partners, Abingworth Management, and Chicago Growth Partners, have provided an additional $15 million investment.

14 Jul 2010

SCENESSE reduces, prevents phototoxic reactions experienced by EPP patients in Phase III trial

A new Australian drug has been shown to assist in protecting patients with a rare genetic disorder that makes their skin toxic to light and UV, and previously forced them to live in the shadows.

13 Jul 2010

TLR7, TLR9 proteins could be culprit behind lupus patients' resistance to steroid treatments: Scientists

Two immune system proteins could be the culprit behind many lupus patients' resistance to widely used steroid treatments, scientists with the Baylor Research Institute in Dallas announced today. It is estimated that more than 5 million people suffer from lupus worldwide.

13 Jul 2010

FRC refutes RCOG claims on fetal pain

The Family Research Council today released a new report that refutes claims made recently by the Royal College of Obstetricians and Gynaecologists' (RCOG) that a fetus is not able to feel pain before 24 weeks of development. RCOG's study is being used to uphold Britain's current legalization of abortions up to 24 weeks.

13 Jul 2010

Governors press Washington for more help, Mass. municipalities seek new authority to cut health care plan costs

The National Governors Association, meeting in Boston, pressed Washington for more help to states. The "NGA renewed its bipartisan appeal for Congress to pass stalled jobs legislation. ... [Last month,] the House and Senate failed to complete legislation that would have extended, through June 2011, important parts of the federal stimulus program enacted last year to provide unemployment insurance and help offset recession-driven cuts to education, health care and public safety.

13 Jul 2010

Efficacy data of Caldolor Injection in treating fever associated with falciparum malaria published

Cumberland Pharmaceuticals Inc. today announced that data supporting the efficacy of Caldolor in treating fever associated with falciparum malaria was published in the July edition of the peer-reviewed American Journal of Tropical Medicine and Hygiene. The study, which is the first to document an antipyretic effect of an injectable non-steroidal anti-inflammatory drug on fever caused by malaria, demonstrated that patients who received intravenous ibuprofen experienced a greater reduction in their temperatures than those who received placebo.

13 Jul 2010

Scientists discover way to enhance nerve regeneration in peripheral nervous system

Faculty of Medicine scientists have discovered a way to enhance nerve regeneration in the peripheral nervous system. This important discovery could lead to new treatments for nerve damage caused by diabetes or traumatic injuries. Peripheral nerves connect the brain and spinal cord to the body, and without them, there is no movement or sensation. Peripheral nerve damage is common and often irreversible. This discovery is published in the July 7, 2010 edition of the Journal of Neuroscience.

12 Jul 2010

Survey shows only few Canadians identify painful physical symptoms of depression

Although the majority of Canadians believe in a mind/body connection, agreeing how they feel physically is related to how they feel emotionally (87 per cent), only half make the link when it comes to depression.

12 Jul 2010

Investment report on Catalyst Pharmaceutical Partners

MicroStockProfit.com announces an investment report featuring Catalyst Pharmaceutical Partners Inc.. The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.

12 Jul 2010

Reducing chronic pain, dry mouth could improve quality of life in head and neck cancer patients: Study

Head and neck cancer patients who reported poor sleep quality one year after diagnosis had more symptoms of chronic pain and complaints of dry mouth related to radiation treatments, according to a recent study from the University of Michigan Comprehensive Cancer Center.

12 Jul 2010

MDT releases statement questioning AGD's priorities

The dentists who form Millennium Dental Technologies, Inc., and are pioneers of the patented LANAP protocol for the treatment of gum disease and the manufacturer of the PerioLase MVP-7 digital dental laser, today released a statement questioning the Academy of General Dentistry's priorities.

12 Jul 2010

Vanderbilt Medical Center treats first patient in Galil Medical's new TRACE renal registry

Galil Medical, a global leader in minimally invasive cryotherapy cancer treatments, today announced that Vanderbilt University Medical Center in Nashville, Tenn., has treated the first patient to be included in its new patient registry.

12 Jul 2010

Hip and knee specialist indicates five primary reasons why knee implant fails

While most knee replacements will function well for years, patients should be aware of the signs of failure—including increased pain or decreased function—that may require a corrective procedure known as revision total knee replacement, if necessary.

12 Jul 2010

Phase III study results of imiquimod creams for treatment of EGW presented at HPV Conference

Results from a Phase III program evaluating imiquimod 3.75% and 2.5% creams for the treatment of EGW, applied once daily for up to 8 weeks, demonstrated that both were well-tolerated and more efficacious than placebo, according to data presented at the annual Human Papillomavirus Conference in Montreal, July 3 - 8. Investigators found that efficacy was greatest for imiquimod 3.75% with an enhanced safety profile.

9 Jul 2010

Length of average Medicare-certified hospice stay in nursing home doubled: Study

Researchers at Brown University have found that the length of an average Medicare-certified hospice stay in a nursing home has doubled during the last 10 years. The study, which will appear in the August issue of The Journal of the American Geriatrics Society, evaluated hospice use in U.S. nursing homes between 1999 and 2006. It found the typical treatment time has increased from 46 to 93 days. The researchers cited a standard daily payment rate for most Medicare hospice enrollment days as an incentive for some of the longer stays.

9 Jul 2010

EPO grants Brookhaven patent for use of vigabatrin in prevention of addiction to opioids

Catalyst Pharmaceutical Partners, Inc. today announced that the European Patent Office (EPO) granted to Brookhaven Science Associates/Brookhaven National Laboratory (Brookhaven) a European patent for the use of vigabatrin for the prevention of addiction to opioids (e.g., oxycodone, hydrocodone) used in pain management.

9 Jul 2010

Pain News and Research

Latest Pain News and Research

SANUWAVE Health introduces orthoPACE device in Europe

Circular external fixator enables over 90% of Charcot foot patients to walk normally again

Telecare management intervention improves pain, depression in cancer patients

Therapeutic workbook to facilitate healing process in Haitian children

Zogenix secures $35M financing for commercial launch of SUMAVEL DosePro needle-free delivery system

SCENESSE reduces, prevents phototoxic reactions experienced by EPP patients in Phase III trial

TLR7, TLR9 proteins could be culprit behind lupus patients' resistance to steroid treatments: Scientists

FRC refutes RCOG claims on fetal pain

Governors press Washington for more help, Mass. municipalities seek new authority to cut health care plan costs

Efficacy data of Caldolor Injection in treating fever associated with falciparum malaria published

Scientists discover way to enhance nerve regeneration in peripheral nervous system

Survey shows only few Canadians identify painful physical symptoms of depression

Investment report on Catalyst Pharmaceutical Partners

Reducing chronic pain, dry mouth could improve quality of life in head and neck cancer patients: Study

MDT releases statement questioning AGD's priorities

Vanderbilt Medical Center treats first patient in Galil Medical's new TRACE renal registry

Hip and knee specialist indicates five primary reasons why knee implant fails

Phase III study results of imiquimod creams for treatment of EGW presented at HPV Conference

Length of average Medicare-certified hospice stay in nursing home doubled: Study

EPO grants Brookhaven patent for use of vigabatrin in prevention of addiction to opioids

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Pain News and Research

Latest Pain News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in